GLP-3 (Retatrutide) Tracker

Direct Answer

DietApp.com's GLP-3 Tracker lets you log retatrutide use, dose history, injection dates, and side effects, the same investigational medication informally nicknamed "GLP-3" for its triple-receptor mechanism, alongside every other GLP-1 medication you're tracking in one place.

What "GLP-3" Actually Means Here

To be clear and accurate: "GLP-3" is not an official medical term, it's shorthand for retatrutide, an investigational medication that activates three separate receptors (GLP-1, GIP, and glucagon) at once, the correct scientific term is triple receptor agonist. Retatrutide is not yet FDA-approved. See our full explainer for the complete picture.

Why Track It Alongside Your Other Medications

Since retatrutide has no established dose steps or pen sizes in any official form, DietApp.com tracks it using the same free-entry approach used for compounded medications, you enter your own dose, letting you keep an accurate, personal record without us inventing figures that don't exist officially.

References

• Coskun T, et al. LY3437943, A Novel Triple GIP, GLP-1, and Glucagon Receptor Agonist. Cell Metabolism (2022)

Related Resources

• What Is "GLP-3"? The Truth Behind This Trending Term
• Retatrutide Medication Guide
• Is Retatrutide FDA-Approved Yet?

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Download DietApp.com to start tracking retatrutide and every other GLP-1 medication in one place.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. Retatrutide is investigational and not FDA-approved. This is for informational purposes only and is not medical advice.